Mangalam Worldwide Ltd. logo

Mangalam Worldwide Limited was incorporated in 1995. It is engaged in the manufacturing of stainless steel (SS). The company manufactures Stainless Steel (SS) Billets and SS Flat Bars. The company is also engaged in the trading of steel - scrap, ferro alloys, etc.

Bidding Dates
30 Jun 2022 - 04 Jul 2022
Subscription
1.33x Oversubscribed
Minimum InvestmentMinimum LotMaximum LotLot SizeNumber of SharesIssue PricePost Issue Promoter Holding %Issue SizeIPO Document
₹1,21,2001112006.5 M₹10173.5 %₹655.8 MRHP DOC

Mangalam Drugs IPO SUBSCRIPTION STATUS

04 Jul '22
Total1.33x
Retail Individual Investor0.46x
HNI (NII) Investors2.2x
Qualified Institutional Buyers-

Mangalam Drugs IPO overall subscription rate was 1.33 times the total available shares

Mangalam Drugs IPO retail subscription rate was 0.46 times in the retail segment

Mangalam Drugs IPO non-institutional investor subscription rate was 2.2 times in the non-institutional investor category

DayRetail Individual InvestorHNI (NII) InvestorsQualified Institutional Buyers
Category Reservation50%50%-
04 Jul 2022
(Day 3)
0.46x2.2x-
01 Jul 2022
(Day 2)
0.13x1.28x-
30 Jun 2022
(Day 1)
0.05x0.44x-

Mangalam Drugs FINANCIALS

Period Net Profit (Rs in millions) Revenue from operations (Rs in millions) Cash Flow from operations (Rs in millions) Free Cash flow (Rs in millions)
FY22 123.10 5,230.29 24.57 -465.63
FY21 26.54 3,019.29 55.78 42.07

Mangalam Drugs IPO SUBSCRIPTION STATUS DETAILS

Mangalam Drugs had 6.5 M shares on offer

Mangalam Drugs IPO offer price was ₹101

Mangalam Drugs IPO minimum Investment was121200

Mangalam Drugs IPO issue size was ₹ 655.8 M

Mangalam Drugs had a minimum lot size of 1200 Shares per application

Mangalam Drugs NUMBER OF SHARES ON OFFER

Total6.5 M
Fresh Issue6.5 M
Offer for Sale0
Post Issue Promoter Holding %73.5 %

Mangalam Drugs IPO IMPORTANT DATES

Issue Open Date30 Jun 2022
Issue close Date04 Jul 2022
Allotment Date07 Jul 2022
Refund Date08 Jul 2022
Demat Account Credit Date11 Jul 2022
Listing Date12 Jul 2022
Listing on Exchange(s)NSE
Mangalam Drugs Allotment StatusExchange

Mangalam Drugs IPO subscription opened on 30 Jun 2022, and closed on 04 Jul 2022

IPO allotment for Mangalam Drugs was finalized on Thursday, 07 Jul 2022

IPO listing for Mangalam Drugs was on NSE on Tuesday, 12 Jul 2022

Mangalam Drugs IPO LISTING GAINS

Issue Price (adjusted)101.0
Listing Open Price150.0
Listing Close Price151.7
Listing Gain%48.5%
Current Gain%-73.1%

Mangalam Drugs Peer

StockStock PriceMarket Cap (Rs crore)PE TTMPEG TTMPS TTMROE%ROA%Annual Revenue (Rs crore)Annual Revenue Growth %Annual Net Profit (Rs crore)Annual Net Profit Growth %EPS TTMEPS TTM Growth %
Mangalam Drugs and Organics Ltd.27.266.6-100.2-43.1-14.1232.9-26.9-44.4-760.6-28.1-760.6
Sun Pharmaceutical Industries Ltd.1945466670.738.62.37.813.710.660433.810.811479.4550.416.6
Divi's Laboratories Ltd.8275219675.375.12.819.615.312.81106714256817.2110.226.8
Torrent Pharmaceuticals Ltd.4924187293.285.99.611.925.84.913886.220.32163.413.257.38.9
Cipla Ltd.1463.8118253.635.1-0.94.211.39.129044.62.23879.2-26.441.7-37.5
Zydus Lifesciences Ltd.1114.2112114.622.22.34.118.69.627657.917.6504011.450.19.6

Mangalam Drugs INFORMATION ON IPO ISSUE

About Mangalam Drugs

Mangalam Worldwide Limited was incorporated in 1995. It is engaged in the manufacturing of stainless steel (SS). The company manufactures Stainless Steel (SS) Billets and SS Flat Bars. The company is also engaged in the trading of steel - scrap, ferro alloys, etc.

Object of the Issue

To Meet Working Capital Requirements.
General Corporate Purpose.
To meet Public Issue Expenses.

Mangalam Drugs - PROMOTERS

Name
Vipin Prakash Mangal
Chanakya Prakash Mangal
Chandragupt Prakash Mangal

Mangalam Drugs Lead Manager To The Issue

Beeline Broking Limited

pcs@beelinebroking.com

Mangalam Drugs Registrar to the Issue

Link Intime India Private Limited

mangalam.ipo@linkintime.co.in

Mangalam Drugs Strengths

Scalable Business Model

The business model is currently driven by the demand of customers in different industry segments, such that the customer is provided with the required goods with minimal delays, and thus achieving economies of scale.

Strength

Long term relationship with Customers

The company has long term relationship with its customers and believes that a long-term client relationship with large clients fetches better dividends

Strength

Cost effective production and timely fulfilment of orders

The company has taken various steps in order to ensure adherence to timely fulfilment and also to achieve greater cost efficiency.

Strength

Mangalam Drugs Risks

Limited experience in the steel industry

The promoters have limited experience in the steel industry, which could have an adverse effect on the Company’s results of operations and financial condition.

Risk

Involved in litigations

The group of companies are involved in certain litigations including tax related litigations.

Risk

Business is dependent on the manufacturing facility

The loss of or shutdown of operations of manufacturing facility may have a material adverse effect on business, financial condition and results of operations.

Risk

IPO FAQs

  • The promoters of the company are Vipin Prakash Mangal, Chanakya Prakash Mangal and Chandragupt Prakash Mangal.

  • The category allocation of qualified institutional buyers is 0.0%, the category allocation of non individual investors or high networth individuals is 50.0% and for retail investors it is 50.0%.

  • The price band of the IPO is Rs 101.0 - 101.0.

  • The IPO application opens on Jun 30, 2022 and closes on Jul 04, 2022.

  • The minimum lot size for the IPO is 1200. The maximum lot size for the IPO is 1200.

  • For all category investors, the minimum application amount for this IPO is Rs. 121,200.0, the maximum value for this IPO is Rs 121,200.0.

  • This IPO will be allotted on Jul 07, 2022.

  • The refund will be credited to your account on Jul 08, 2022.

  • The allotted shares will be credited to your demat on Jul 11, 2022.

  • Mangalam Worldwide Ltd.’s shares listed on the stock exchanges on Jul 12, 2022.